Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Tanya B. Dorff, MD, professor within the Division of Medical Oncology and Therapeutics Analysis and division chief of the Genitourinary Illness Program at...
Chemical substances and reagentsSolvents and reagents employed have been of HPLC or LC–MS grade. Acetonitrile, chloroform, isopropanol, methyl tert-butyl ether (MTBE) have been...
